Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of Marius Pharmaceuticals.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Marius Pharmaceuticals
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
8601 Six Forks Road Suite 630 Raleigh, NC 27615
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Kyzatrex (testosterone undecanoate) is a proprietary oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: KYZATREX

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 09, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

KYZATREX™ (testosterone undecanoate) is a proprietary softgel oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: Kyzatrex

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 18, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

The partnership aims at addressing the pressing global issue of hypogonadism through the launch of a comprehensive Early Access Program for Kyzatrex (testosterone undecanoate), a proprietary softgel oral formulation absorbed primarily via the lymphatic system.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Kyzatrex

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: Smartway Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership August 10, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

KYZATREX™ (testosterone undecanoate) is a proprietary softgel oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Kyzatrex

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 21, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

KYZATREX™ is an oral testosterone replacement therapy ("TRT") indicated in adult males for conditions associated with a deficiency or absence of endogenous testosterone, also known as hypogonadism.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Kyzatrex

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 02, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

KYZATREX®, an oral testosterone undecanoate softgel, had one of the most comprehensive Phase 3 trials in the testosterone space and if approved, has the potential to be the only first-action approval oral testosterone product on the market.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Kyzatrex

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 11, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

KYZATREX® has generated strong results in both safety and efficacy studies for KYZATREX® for treatment of primary and secondary hypogonadism in men.


Lead Product(s): Testosterone Undecanoate

Therapeutic Area: Endocrinology Product Name: Kyzatrex

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 05, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY